The Advisory Team at WntRx Pharmaceuticals provides strategic guidance and expert insights to support the development of innovative, non-toxic drugs targeting Wnt signaling in colorectal cancer and other critical unmet medical needs. Comprised of specialized advisors, the team plays a crucial role in shaping research directions, clinical strategies, and regulatory pathways.
View all